Curated News
By: NewsRamp Editorial Staff
September 24, 2026
Creative Biolabs Expands Plant-Derived EV Research Services
TLDR
- Creative Biolabs now offers custom plant-derived EV services, giving researchers a pipeline advantage in nanovesicle isolation, cargo loading, and preclinical evaluation.
- Creative Biolabs supports plant-derived EV research through a workflow of isolation, purification, NTA, TEM, WB characterization, cargo loading, and in vitro and in vivo evaluation.
- Creative Biolabs advances plant-derived EV research that may improve biocompatible delivery systems for skin repair, oral medicine, and immune health.
- Edible plants like strawberries, grapefruit, and garlic yield extracellular vesicles now studied as natural nanoscale delivery vehicles for drugs and RNA.
Impact - Why it Matters
This news matters because plant-derived extracellular vesicles represent a promising frontier in nanomedicine, offering a natural, biocompatible alternative to synthetic delivery systems. By providing comprehensive services for isolation, characterization, and cargo loading, Creative Biolabs enables researchers to rigorously study vesicles from edible plants like strawberry, grapefruit, and garlic. These vesicles could lead to innovative treatments for skin conditions, gastrointestinal disorders, and inflammatory diseases, as well as improved oral drug delivery. The systematic approach addresses critical challenges of variability, helping to translate plant-derived EV research into reproducible experimental models and, eventually, clinical applications. This expansion supports the global scientific community in exploring the full potential of these biological nanoparticles.
Summary
Creative Biolabs has expanded its plant-derived extracellular vesicle (PDEV) research services to support the isolation, purification, characterization, cargo loading, and preclinical evaluation of vesicles from edible plant sources. These nanoscale delivery systems, including exosome-like nanovesicles, are being investigated as alternatives to synthetic nanoparticles due to their natural origin, potential scalability, and reported biocompatibility in experimental models. The company now offers tailored services for specific plant-derived EVs, such as Strawberry-derived EVs for skin biology and tissue-repair research, Grapefruit-derived EVs for oral delivery and gastrointestinal studies, and Garlic-derived EVs for inflammation, microbial, and immune research. Each plant source offers unique cargos and properties that researchers can explore for various applications.
The core message from Creative Biolabs emphasizes the importance of a systematic workflow to address the variability in PDEV composition and function. Their platform covers the entire experimental pipeline, from isolating and purifying crude plant extracts to multi-dimensional characterization using NTA, TEM, and WB, as well as experimental cargo loading with small molecules, siRNAs, and peptides. Subsequent in vitro and in vivo biological activity assessments help researchers compare vesicles and investigate their potential. A company scientist noted that plant-derived EVs are attracting growing interest because their properties vary substantially across plant sources, and a systematic approach can aid researchers in comparing these vesicles and exploring their potential in different experimental applications. For more information, visit https://www.creative-biolabs.com/exosome/. This service is for research use only, not for diagnostic or therapeutic procedures.
Source Statement
This curated news summary relied on content distributed by 24-7 Press Release. Read the original source here, Creative Biolabs Expands Plant-Derived EV Research Services
